Supplier of antibodies, proteins, lysates and research reagents
GeneTex, Inc. started operations in early 1997 in San Antonio, Texas. GeneTex was founded by three internationally renowned scientists with recognized expertise in clinical oncology, cancer biology and infectious diseases. Based on their breadth of experience and research interests, the company’s initial focus was breast cancer biology and prognostic marker research. This evolved to incorporate a comprehensive portfolio of immunological reagents used by scientists studying the underlying mechanisms common to many forms of cancer.
GeneTex’s product portfolio has expanded to cover research areas including cancer, cell biology, epigenetics, immunology, infectious disease, metabolism, neuroscience, signal transduction, stem cell development and zebrafish biology.
Bio-Connect Life Sciences supplies all their products in the Benelux. If you have any questions, please contact the helpdesk.
Major product lines from GeneTex
- Cell and tissue lysates
- Primary antibodies
- Proteins and peptides
- Secondary antibodies
- Serum products
SARS-CoV-2 spike antibodies
GeneTex antibodies that may detect the Omicron spike protein based on immunogen sequence analysis.
|Spike RBD antibody [HL257] (GTX635692)|
|Spike S1 antibody [HL1] (GTX635656)|
|Spike S2 antibody [HL237] (GTX635693)|
|Spike antibody [1A9] (GTX632604)|
|Spike antibody (GTX135360)|
|Spike RBD antibody (GTX135385)|
|Spike S2 / S2′ antibody (GTX135386)|
GeneTex antibody trial program
Do you want to test an antibody first? Try GeneTex’s antibody samples (10 µl) for only €10.